(-)-UH 232
(-)-UH 232 is a central dopamine (DA) receptor agonist. (-)-UH 232 weakly decreases 3, 4-dihydroxyphenylalanine (DOPA) formation in striatal and limbic brain regions in rats. (-)-UH 232 can be used for the research of neurological diseases including parkinson's disease and schizophrenia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 95999-11-4
- 分子式: C18H29NO
- 分子量:275.44
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Dopamine Receptor アイソフォーム固有の製品をすべて表示
More
生物活性
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley rats (male, 200-300 g)[1]
-
Dosage:0.8, 3.2, 13, 52, 204 μmol/kg
-
Administration:s.c.; single dose
-
Result:Failed to significantly influence locomotor activity in non-pretreated rats at doses up to 52 μmol/kg.
Did not antagonize Reserpine (HY-N0480)-induced hypomotility at 204 μmol/kg.
Produced a weak trend towards reduced cortical DOPA formation, with a significant 15% decrease only at 52 μmol/kg in non-pretreated rats.
Dose-dependently decreased DOPA formation in limbic and striatal regions of reserpinized rats.
化学情報
-
CAS 番号 95999-11-4
-
分子量 275.44
-
分子式 C18H29NO
-
SMILES
O(C)C1=C2C([C@@H](C)[C@@H](N(CCC)CCC)CC2)=CC=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
- (-)-UH 232
- 95999-11-4
- Dopamine Receptor
- non-pretreated rats
- parkinson's disease
- reserpine-induced akinesia
- schizophrenia
- neurological diseases
- dopamine receptor modulation models
- striatum
- brain regions
- Sprague-Dawley rats
- reserpinized rats
- DOPA formation
- dopamine (DA) receptor agonist
- limbic region
- Inhibitor
- inhibitor
- inhibit